Smith & Nephew SNATS (SNN)
(Delayed Data from NYSE)
$24.14 USD
+0.01 (0.04%)
Updated May 1, 2024 04:00 PM ET
After-Market: $24.14 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value B Growth B Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
SNN 24.14 +0.01(0.04%)
Will SNN be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for SNN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SNN
Smith+Nephew (SNN) Expands in Australia With New Alliance
Fresenius Medical (FMS) to Unveil Training on Augmented Reality
SNN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are Investors Undervaluing Smith & Nephew SNATS (SNN) Right Now?
Should Value Investors Buy Phibro Animal Health (PAHC) Stock?
Is Smith & Nephew SNATS (SNN) Stock Undervalued Right Now?
Other News for SNN
LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC
Q1 2024 Sales/ Trading Statement Call
LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage
Smith & Nephew confident for full-year despite mixed first quarter
LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed